Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D02JVI
|
||||
| Former ID |
DNC004657
|
||||
| Drug Name |
1-Benzooxazol-2-yl-6-phenyl-hexan-1-one
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [527476] | ||
| Formula |
C19H19NO2
|
||||
| Canonical SMILES |
C1=CC=C(C=C1)CCCCCC(=O)C2=NC3=CC=CC=C3O2
|
||||
| InChI |
1S/C19H19NO2/c21-17(19-20-16-12-7-8-14-18(16)22-19)13-6-2-5-11-15-9-3-1-4-10-15/h1,3-4,7-10,12,14H,2,5-6,11,13H2
|
||||
| InChIKey |
PCLBCMUYLOBYMW-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Fatty-acid amide hydrolase | Target Info | Inhibitor | [527476] | |
| BioCyc Pathway | Anandamide degradation | ||||
| KEGG Pathway | Retrograde endocannabinoid signaling | ||||
| PANTHER Pathway | Anandamide degradation | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.